🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the side effects and how well nivolumab and ibr...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2019-02-15
Trial ID
NCT03770416
This phase II trial tests how well ibrutinib works in preventing chronic gr...
Status
Terminated
Location
Mayo Clinic in Florida
Start Date
2024-12-13
Trial ID
NCT06271616
Treatments Being Tested
The main objective of this study is to evaluate the efficacy of the combina...
Status
Completed
Location
Dana-Farber Cancer Institute /ID# 207728
Start Date
2020-01-14
Trial ID
NCT03873493
Treatments Being Tested
This randomized phase III trial studies rituximab with bendamustine hydroch...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-15
Trial ID
NCT01886872
TP-0903 is an inhibitor of AXL kinase. TP-0903 has shown potent inhibition ...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2019-06-10
Trial ID
NCT03572634
Treatments Being Tested
The aim of this study is to test the potential benefit of an innovative com...
Status
Completed
Location
CH Annecy Genevois - Hématologie A3
Start Date
2019-09-27
Trial ID
NCT04010968
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of ibrutinib w...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2017-01-12
Trial ID
NCT02950220
Treatments Being Tested
This is a phase 3 study to evaluate the efficacy of ibrutinib in combinatio...
Status
Completed
Location
Oncology Specialties, PC; Clearview Cancer Institute
Start Date
2015-05
Trial ID
NCT02436668
Treatments Being Tested
In Waldenström macroglobulinemia (WM) chemotherapy induces only low CR/VGPR...
Status
Active Not Recruiting
Location
Uniklinikum Salzburg
Start Date
2021-08-18
Trial ID
NCT04263480
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of ibrutini...
Status
Completed
Location
Site Reference ID/Investigator# 0241
Start Date
2014-10-06
Trial ID
NCT02264574
Treatments Being Tested